Literature DB >> 31521478

Antibacterial activity of 2-amino-4-hydroxypyrimidine-5-carboxylates and binding to Burkholderia pseudomallei 2-C-methyl-d-erythritol-2,4-cyclodiphosphate synthase.

Sydney M Watkins1, Debarati Ghose2, Joy M Blain1, Dakota L Grote1, Chi-Hao Luan3, Michael Clare4, R Meganathan2, James R Horn1, Timothy J Hagen5.   

Abstract

Enzymes in the methylerythritol phosphate pathway make attractive targets for antibacterial activity due to their importance in isoprenoid biosynthesis and the absence of the pathway in mammals. The fifth enzyme in the pathway, 2-C-methyl-d-erythritol-2,4-cyclodiphosphate synthase (IspF), contains a catalytically important zinc ion in the active site. A series of de novo designed compounds containing a zinc binding group was synthesized and evaluated for antibacterial activity and interaction with IspF from Burkholderia pseudomallei, the causative agent of Whitmore's disease. The series demonstrated antibacterial activity as well as protein stabilization in fluorescence-based thermal shift assays. Finally, the binding of one compound to Burkholderia pseudomallei IspF was evaluated through group epitope mapping by saturation transfer difference NMR.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial activity; Burkholderia pseudomallei IspF; Fluorescence-based thermal shift; Kirby Bauer disk diffusion; MEP pathway; STD-NMR

Mesh:

Substances:

Year:  2019        PMID: 31521478      PMCID: PMC7006361          DOI: 10.1016/j.bmcl.2019.126660

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  18 in total

1.  Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors.

Authors:  David T Puerta; Seth M Cohen
Journal:  Inorg Chem       Date:  2003-06-02       Impact factor: 5.165

2.  The isoprene rule and the biogenesis of terpenic compounds.

Authors:  L RUZICKA
Journal:  Experientia       Date:  1953-10-15

3.  Using model complexes to augment and advance metalloproteinase inhibitor design.

Authors:  Faith E Jacobsen; Seth M Cohen
Journal:  Inorg Chem       Date:  2004-05-17       Impact factor: 5.165

4.  Probing chelation motifs in HIV integrase inhibitors.

Authors:  Arpita Agrawal; Jamie DeSoto; Jessica L Fullagar; Kasthuraiah Maddali; Shahrzad Rostami; Douglas D Richman; Yves Pommier; Seth M Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-27       Impact factor: 11.205

5.  1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.

Authors:  Rakesh K Dhiman; Merrill L Schaeffer; Ann Marie Bailey; Charles A Testa; Hataichanok Scherman; Dean C Crick
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

6.  Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate.

Authors:  M Rohmer; M Knani; P Simonin; B Sutter; H Sahm
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

7.  Cross-species comparison of the Burkholderia pseudomallei, Burkholderia thailandensis, and Burkholderia mallei quorum-sensing regulons.

Authors:  Charlotte D Majerczyk; Mitchell J Brittnacher; Michael A Jacobs; Christopher D Armour; Matthew C Radey; Richard Bunt; Hillary S Hayden; Ryland Bydalek; E Peter Greenberg
Journal:  J Bacteriol       Date:  2014-09-02       Impact factor: 3.490

8.  Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.

Authors:  Vincenzo Summa; Alessia Petrocchi; Fabio Bonelli; Benedetta Crescenzi; Monica Donghi; Marco Ferrara; Fabrizio Fiore; Cristina Gardelli; Odalys Gonzalez Paz; Daria J Hazuda; Philip Jones; Olaf Kinzel; Ralph Laufer; Edith Monteagudo; Ester Muraglia; Emanuela Nizi; Federica Orvieto; Paola Pace; Giovanna Pescatore; Rita Scarpelli; Kara Stillmock; Marc V Witmer; Michael Rowley
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

9.  New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.

Authors:  David T Puerta; Jana A Lewis; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2004-07-14       Impact factor: 15.419

Review 10.  Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agents.

Authors:  Tiziana Masini; Anna K H Hirsch
Journal:  J Med Chem       Date:  2014-09-25       Impact factor: 7.446

View more
  1 in total

1.  Structural and biophysical characterization of the Burkholderia pseudomallei IspF inhibitor L-tryptophan hydroxamate.

Authors:  Joy M Blain; Dakota L Grote; Sydney M Watkins; Gashaw M Goshu; Chanté Muller; James L Gorman; Gina Ranieri; Richard L Walter; Heike Hofstetter; James R Horn; Timothy J Hagen
Journal:  Bioorg Med Chem Lett       Date:  2021-07-21       Impact factor: 2.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.